Inventor
SATO AARON
US32 patents
⚠️ This page may combine multiple inventors who share the name “SATO AARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TWIST BIOSCIENCE CORP
16 patentsUS11492727B2Nov 8, 2022
Variant nucleic acid libraries for GLP1 receptor
TWIST BIOSCIENCE CORP6 citations84
US11492728B2Nov 8, 2022
Variant nucleic acid libraries for antibody optimization
TWIST BIOSCIENCE CORP5 citations84
US12565715B2Mar 3, 2026
Variant nucleic acid libraries for antibody optimization
TWIST BIOSCIENCE CORP0 citations62
US12553151B2Feb 17, 2026
Variant nucleic acid libraries for glycans
TWIST BIOSCIENCE CORP0 citations62
US12331427B2Jun 17, 2025
Antibodies that bind GLP1R
TWIST BIOSCIENCE CORP0 citations61
US12173282B2Dec 24, 2024
Antibodies that bind CD3 epsilon
TWIST BIOSCIENCE CORP0 citations61
US12304965B2May 20, 2025
Variant nucleic acid libraries for coronavirus
TWIST BIOSCIENCE CORP0 citations60
US12201857B2Jan 21, 2025
Methods and compositions relating to covid antibody epitopes
TWIST BIOSCIENCE CORP0 citations60
US12018065B2Jun 25, 2024
Variant nucleic acid libraries for coronavirus
TWIST BIOSCIENCE CORP0 citations60
US12202905B2Jan 21, 2025
Methods and compositions relating to adenosine receptors
TWIST BIOSCIENCE CORP0 citations59
US12258406B2Mar 25, 2025
Antibodies that bind CD3 Epsilon
TWIST BIOSCIENCE CORP0 citations57
US12325739B2Jun 10, 2025
Bispecific SARS-CoV-2 antibodies and methods of use
TWIST BIOSCIENCE CORP0 citations52
US12570750B2Mar 10, 2026
Antibodies that bind adenosine A2A receptors and methods of use thereof to treat cancer and neurological diseases
TWIST BIOSCIENCE CORP0 citations51
US12391762B2Aug 19, 2025
Methods and compositions relating to GLP1R variants
TWIST BIOSCIENCE CORP0 citations51
US12091777B2Sep 17, 2024
Variant nucleic acid libraries for CRTH2
TWIST BIOSCIENCE CORP0 citations51
US12134656B2Nov 5, 2024
Dickkopf-1 variant antibodies and methods of use
TWIST BIOSCIENCE CORP0 citations46
SUTRO BIOPHARMA INC
5 patentsUS11708413B2Jul 25, 2023
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
SUTRO BIOPHARMA INC3 citations71
US10975150B2Apr 13, 2021
Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodies
SUTRO BIOPHARMA INC1 citations61
US11014983B2May 25, 2021
Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies
SUTRO BIOPHARMA INC0 citations51
US10822414B2Nov 3, 2020
Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies
SUTRO BIOPHARMA INC0 citations51
US11098131B2Aug 24, 2021
Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies
SUTRO BIOPHARMA INC0 citations48
DYAX CORP
3 patentsUS8044175B2Oct 25, 2011
Peptides that specifically bind HGF receptor (CMET) and uses thereof
DYAX CORP44 citations98
US7261876B2Aug 28, 2007
Multivalent constructs for therapeutic and diagnostic applications
DYAX CORP33 citations96
US7211240B2May 1, 2007
Multivalent constructs for therapeutic and diagnostic applications
DYAX CORP52 citations95